Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - ATOSSA THERAPEUTICS, INC. | v459198_ex5-1.htm |
| S-1 - S-1 - ATOSSA THERAPEUTICS, INC. | v459198_s1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Atossa Genetics Inc.
Seattle, Washington
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated March 30, 2016, relating to the consolidated financial statements of Atossa Genetics Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Seattle, Washington
February 13, 2017